Outlook Therapeutics (OTLK) EBIT Margin (2015 - 2025)
Outlook Therapeutics (OTLK) reported EBIT Margin of 18863.9% for Q3 2025, up 1903.09% quarter-over-quarter from 1046.2% in Q2 2025.
Outlook Therapeutics (OTLK) EBIT Margin (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has 6 years of EBIT Margin data on file, last reported at 18863.9% in Q3 2025.
- EBIT Margin for Q3 2025 came in at 18863.9%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was 854.19% (changed N/A YoY), and the FY2025 annual result was 4744.25%, changed N/A from the prior year.
- EBIT Margin climbed to 18863.9% in Q3 2025 per OTLK's latest filing, from 1046.2% in the prior quarter.
- Over five years, EBIT Margin peaked at 18863.9% in Q3 2025 and troughed at 1046.2% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18,863.90% |
| Jun 30, 2025 | -1,046.20% |
| Sep 30, 2019 | -216.83% |
| Jun 30, 2019 | -966.72% |
| Mar 31, 2019 | -1,201.86% |
| Dec 31, 2018 | -960.78% |
| Sep 30, 2018 | -1,608.21% |
| Jun 30, 2018 | -935.35% |
| Mar 31, 2018 | -884.97% |
| Dec 31, 2017 | -411.95% |
| Sep 30, 2017 | -100.29% |
| Jun 30, 2017 | -2,420.14% |
| Mar 31, 2017 | -2,585.60% |
| Dec 31, 2016 | -5,870.30% |
| Sep 30, 2016 | -2,011.04% |
| Jun 30, 2016 | -4,450.95% |
| Mar 31, 2016 | -296.91% |
| Dec 31, 2015 | -1,649.75% |
| Sep 30, 2015 | -3,510.23% |
| Jun 30, 2015 | -853.02% |